Eisner Mark bought VIR
February 22, 2026 · Form 4 insider transaction
Eisner Mark bought 55,000 shares of Vir Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
55,000
Price
$0.00
Total value
N/A
InsiderEisner Mark
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 22, 2026
Filing dateFebruary 24, 2026
Shares owned after159,618
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.